Statistics for Array BioPharma (id:6416 ARRY)

Valuation metrics

Market cap

1.16B

Enterprise value

1.77B

Trailing P/E (ttm)

61.85

Forward P/E

8.67

PEG ratio

8.67

Price/Sales (ttm)

1.18

Price/Book (mrq)

18.00

Enterprise Value/Revenue

1.80

Enterprise Value/EBITDA

12.40

Overview

Shares outstanding

151.94M

Float

138.06M

Shares short

29.65M

% Held by insiders

0.00%

% Held by institutions

1.25%

Average volume (10 days)

13.40M

Average volume (90 days)

Price summary

52-Week low

5.56

52-Week high

20.15

52-Week change

-140.82%

Beta

1.61

50-Day moving average

6.58

200-Day moving average

10.48

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-9.59%

Operating margin

12.66%

Operational effectiveness

Return on assets

3.89%

Return on equity

-17.54%

Income statement

Revenue (ttm)

6.48

Revenue per share (ttm)

6.48

Quarterly revenue growth (yoy)

Gross profit (ttm)

415.55M

EBITDA

173.89M

Net income to common (ttm)

-148,812,992.00

Diluted EPS (ttm)

-0.98

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

332.37M

Total cash per share (mrq)

2.19

Total debt (mrq)

693.26M

Total Debt/Equity (mrq)

151.67

Current ratio (mrq)

240.70%

Book value per share (mrq)

0.42

Cash flow

Cash flow statement

190.38M

Levered free cash flow (LFCF)

211.89M